Which of the fluorine-18 fluorodeoxyglucose positron emission tomography/computerized tomography parameters are better associated with prognostic factors in breast cancer?-Reference-Cited by-同舟云学术

Which of the fluorine-18 fluorodeoxyglucose positron emission tomography/computerized tomography parameters are better associated with prognostic factors in breast cancer?

Published:2019-05 Issue:22 Volume:98 Page:e15925
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Önner Hasan,Canaz Funda,Dinçer Murat,Işiksoy Serap,Sivrikoz İlknur AK,Entok Emre,Erkasap Serdar

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference42 articles.

1. Prognostic factors in breast cancer: College of American Pathologists consensus statement 1999;Fitzgibbons;Arch Pathol Lab Med,2000

2. Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015;Coates;Ann Oncol,2015

3. Performance of FDG PET/CT in the clinical management of breast cancer;Groheux;Radiology,2013

4. Correlation of the value of 18F-FDG uptake, described by SUVmax, SUVavg, metabolic tumour volume and total lesion glycolysis, to clinicopathological prognostic factors and biological subtypes in breast cancer;Kajáry;Nucl Med Commun,2015

5. The relationship between 18F-FDG metabolic volumetric parameters and clinicopathological factors of breast cancer;Kaida;Nucl Med Commun,2013

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluación del papel de la sarcopenia y de los parámetros de la PET/TC con [18F]FDG en el pronóstico del adenocarcinoma ductal de páncreas;Revista Española de Medicina Nuclear e Imagen Molecular;2024-09

2. Evaluating the role of sarcopenia and [18F]FDG PET/CT parameters in prognosis of pancreatic ductal adenocarcinoma;Revista Española de Medicina Nuclear e Imagen Molecular (English Edition);2024-08

3. Clinicopathological and molecular predictors of [18F]FDG-PET disease detection in HER2-positive early breast cancer: RESPONSE, a substudy of the randomized PHERGain trial;European Journal of Nuclear Medicine and Molecular Imaging;2024-04-08

4. Accuracy of positron emission tomography-computed tomography in the assessment of metabolically negative axillary lymph nodes in breast cancer;The Egyptian Journal of Surgery;2024-03-22

5. Predictive value of 18F-FDG PET/CT-based radiomics model for neoadjuvant chemotherapy efficacy in breast cancer: a multi-scanner/center study with external validation;European Journal of Nuclear Medicine and Molecular Imaging;2023-02-20